2m 2m 2m 2m 2m 2m 2m
BOUNDLESS BIO (BOLD)
NASDAQ
$2.62+$0.03 (+1.16%)
Price as of Oct 02, 2026 5:47 PM EDT- $58.9MMarket Cap
- 114.05%1-Year Change
- BiotechnologyIndustry
BOUNDLESS BIO (BOLD)
$2.62+$0.03 (+1.16%)
BOLD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.59 | ||
Change | +$0.08 (+3.19%) | ||
Open | $2.49 | ||
High | $2.62 | ||
Low | $2.49 | ||
Previous Close | $2.51 | ||
Volume | 163,785 | ||
30-Day Average Volume | 133,148 | ||
1-Week Change | -0.38% | ||
1-Month Change | -10.38% | ||
1-Year Change | 114.05% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 22.7M | ||
Total Assets | $73.7M | ||
Market Cap | $58.9M | ||
Enterprise Value | $38.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$23.7M | ||
Free Cash Flow | -$21.0M | ||
EBIT | -$23.7M | ||
EBITDA | -$22.4M | ||
Net Working Capital | $65.9M | ||
EPS | -$1.06 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue